Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,157 | 1,083 | 2,322 | 1,666 | 0 |
| Cost of Goods | 3,925 | 2,962 | 3,070 | 1,577 | N/A |
| Gross Profit | -2,768 | -1,879 | -748 | 89 | N/A |
| Operating Expenses | 84,558 | 65,472 | 48,022 | 51,795 | 48,741 |
| Operating Income | -86,401 | -66,389 | -48,700 | -51,129 | -48,741 |
| Other Income | 7,345 | 6,187 | 7,391 | 7,321 | 7,315 |
| Pre-tax Income | -79,056 | -60,202 | -41,309 | -43,808 | -41,426 |
| Net Income Continuous | -79,056 | -60,202 | -41,309 | -43,808 | -41,426 |
| Net Income | $-79,056 | $-60,202 | $-41,309 | $-43,808 | $-41,426 |
| EPS Basic Total Ops | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 |
| EPS Basic Continuous Ops | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 |
| EPS Diluted Total Ops | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 |
| EPS Diluted Continuous Ops | -0.90 | -0.71 | -0.52 | -0.57 | -0.54 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.71 | -0.51 | -0.57 | -0.54 |
| EBITDA(a) | $-87,215 | $-63,884 | $-46,900 | $-52,678 | $-48,306 |